POAG detection successful with tract-based spatial imaging

Article

Tract-based spatial statistical analysis of diffusion tensor imaging is a successful tool for the detection of cortical nerve fibre loss in primary open-angle glaucoma (POAG) patients, claims a recent paper.

Tract-based spatial statistical analysis of diffusion tensor imaging is a successful tool for the detection of cortical nerve fibre loss in primary open-angle glaucoma (POAG) patients, claims a recent paper.

Dr Zhiqi Chen et al., Department of Ophthalmology, Tongji Hospital, Shanghai City, China, devised a cross-sectional investigation consisting of 25 patients with POAG and 24 healthy control subjects.

All participants underwent thorough ophthalmological assessments, including cup-to-disc ratio, retinal nerve fibre layer thickness and a visual field test. The main outcome measures were diffusivity changes of the nerve fibres in the visual pathway, mean diffusivity and fractional anisotrophy. All measurements were compared with ophthalmological data.

Bilateral optic tracts and optic radiations in POAG patients demonstrated significantly decreased fractional anisotrophy and increased mean diffusivity, compared to the control group.

The fractional anisotrophy of the optic tracts and optic radiations consistently varied with cup-to-disc ratio, retinal nerve fibre layer thickness and visual function analysis, respectively.

There was no significant correlation between the mean diffusivity of the optic radiations and the ophthalmological measurements. But the mean diffusivity of the optic tracts correlated with the ophthalmological measurements.

Optic tracts and optic radiations of POAG patients revealed radiological evidence of neurodegeneration, which varied with optic disc damage and loss of visual function.

The abstract can be found in the journal Clinical and Experimental Ophthalmology.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.